According to IDEAYA Biosciences's latest financial reports the company has $0.52 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.52 B | 43.93% |
2022-12-31 | $0.36 B | 47.84% |
2021-12-31 | $0.24 B | -12.98% |
2020-12-31 | $0.28 B | 186.58% |
2019-12-31 | $98.95 M | 10% |
2018-12-31 | $89.96 M | 583.75% |
2017-12-31 | $13.15 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -60.35% | ๐บ๐ธ USA |